跳至主要内容
临床试验/CTRI/2019/09/021275
CTRI/2019/09/021275尚未招募未知

Comparative study of Ormeloxifene versus Medroxyprogesterone Acetate in abnormal uterine bleeding in perimenopausal women

ivedita Chawla0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All perimenopausal females between the age of 39 to 51 years with abnormal uterine bleeding.

排除标准

  • a.Pregnancy
  • b.Organic Pelvic Pathology like polyp, fibroid, adenomyosis, endometriosis
  • c.Systemic Pathology
  • d.Coagulation disorders
  • e.Breast malignancy
  • f.Endometrial Hyperplasia with atypia
  • g.Endocrine disorders like hypothyroidism

研究者

发起方
ivedita Chawla

相似试验